Published: 2 December 2021

Publications

Quarterly summary of recent safety communications

Published: 2 December 2021
Prescriber Update 42(4): 59
December 2021

The table below is a summary of recent safety communications to health care professionals and consumers, published on the Medsafe website.

Date Communication Topic
  COVID-19 Adverse events following immunisation with COVID-19 vaccines
17/11/2021 Monitoring Menstrual disorders and unexpected vaginal bleeding – Comirnaty (Pfizer COVID-19 vaccine)
17/11/2021 Monitoring COVID-19 vaccination in pregnancy: no safety concerns with Comirnaty (Pfizer COVID-19 vaccine)
15/11/2021 Alert Consent to distribute medicines containing bufexamac was revoked on 9 November 2021
21/10/2021 Dear Healthcare Professional Letter Supply of Actemra (tocilizumab) 162 mg/0.9 mL solution for subcutaneous (PDF, 4 pages, 753 KB)
11/10/2021 Dear Healthcare Professional Letter Supply of Actemra (tocilizumab) for hospital use (PDF, 4 pages, 753 KB)
06/09/2021 Dear Healthcare Professional Letter Notification of temporary supply shortage for Actemra (tocilizumab) (PDF, 2 pages, 215 KB)
06/09/2021 Alert Risks of importing or prescribing ivermectin for prevention or treatment of COVID-19

 

Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /